Trans-Tranilast
Product Specifications
CAS Number
70806-55-2
Target
RAAS
Related Pathways
Endocrinology/Hormones
Purity
0.9996
Bioactivity
Trans-Tranilast is an antiallergic drug developed by Kissei Pharmaceuticals. It was approved in 1982 for use in Japan and South Korea for bronchial asthma. Indications for keloid and hypertrophic scar were added in 1993. It has been used for the treatment of allergic disorders such as asthma, allergic rhinitis and atopic dermatitis.
Smiles
N(C(/C=C/C1=CC(OC)=C(OC)C=C1)=O)C2=C(C(O)=O)C=CC=C2
Molecular Formula
C18H17NO5
Molecular Weight
327.33
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
CSB-EP363948EODa6-01 20 µg
Recombinant Escherichia coli O157:H7 Large-conductance mechanosensitive channel (mscL)
Ask
View Details 
CSB-EP363948EODa6-02 100 µg
Recombinant Escherichia coli O157:H7 Large-conductance mechanosensitive channel (mscL)
Ask
View Details 
CSB-EP363948EODa6-03 1 mg
Recombinant Escherichia coli O157:H7 Large-conductance mechanosensitive channel (mscL)
Ask
View Details GTR15177039 1 Vial
Lentiviral mouse Tekt2 shRNA (UAS) - Lentiviral mouse Tekt2 shRNA (UAS, iRFP) (100)
Ask
View Details 483772 100 µL
ITIH1 (Inter-Alpha-Trypsin Inhibitor Heavy Chain 1, cDNA FLJ51523, Highly Similar to Inter-Alpha-Trypsin Inhibitor Heavy Chain H1 EMBL BAH12794.1)
Ask
View Details